Cargando…
Beclin1 haploinsufficiency compromises mesenchymal stem cell-offered cardioprotection against myocardial infarction
Mesenchymal stem cells (MSCs)-based therapy has displayed some promises in ischemia heart diseases although its efficacy may be affected by changes in surrounding environments. This study evaluated the role of autophagy insufficiency using Beclin1 haploinsufficiency (BECN(+/−)) on intra-myocardial M...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160171/ https://www.ncbi.nlm.nih.gov/pubmed/35650374 http://dx.doi.org/10.1186/s13619-022-00121-y |